Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing Requirements
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) — Collective Audience, Inc. (NASDAQ-GM: CAUD) has received an additional notification from the […]
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) — Collective Audience, Inc. (NASDAQ-GM: CAUD) has received an additional notification from the […]
JERICHO, N.Y., May 30, 2024 (GLOBE NEWSWIRE) — Kimco Realty® (NYSE: KIM) announced today that members of its management team […]
GRAPEVINE, Texas, May 30, 2024 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that it […]
Grew revenue by 43% year-over-year to $82.3 million and non-GAAP revenue by 46% Delivered net income of $9.3 million, representing […]
FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today […]
Westport, CT, May 30, 2024 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology […]
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK […]
Of the evaluable ICI-naïve MSS/MSI-L CRC patients without liver metastasis, there were 2 confirmed ongoing PRs and a disease control […]
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat […]
SANTA CLARA, Calif., May 30, 2024 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced […]